Alzheimers Research UK logo

Alzheimer’s Research UK Welcomes Global Action Plan to Defeat Dementia

The UK’s leading dementia research charity, Alzheimer’s Research UK, has welcomed a global action plan, endorsed by the World Health Assembly, to tackle dementia and improve the lives of those living with the condition.

Today, delegates at the World Health Assembly have given the green light to the global action plan on the public health response to dementia 2017-2025 and committed to developing ambitious national strategies and implementation plans. Areas for action include: reducing the risk of dementia; diagnosis, treatment and care; research and innovative technologies; and development of supportive environments for carers.

Delegates also called on the World Health Organisation Secretariat to offer technical support, tools and guidance to Member States as they develop national and subnational plans and to draw up a global research agenda for dementia.

Dr Matthew Norton, Director of Policy and Strategy at Alzheimer’s Research UK, said:

“The global action plan is an incredibly positive step forward for dementia and highlights that the World Health Assembly is committed to bringing an end to the devastation caused by the condition. Dementia is our greatest medical challenge and if we are to defeat it, then we must work together. For the ambitions outlined in this plan to be achieved, there must be leadership and a co-ordinated plan, and it will be important for the WHO Secretariat to offer support for countries as national plans are developed. In the UK, we have already seen the impact an action plan can have, with increased funding leading to increases in the number of researchers working on dementia and more breakthroughs being made. It will be crucial for the UK and other countries to share their experiences to help shape this global plan.

“At Alzheimer’s Research UK, we’re committed to helping bring about a life-changing treatment for those living with dementia by 2025. We know that the only way to do this is by investing in pioneering research and collaboration is a key part of this. As an organisation, we are dedicated to working globally to reach the breakthrough we so desperately need and we are delighted to see that the delegates of the World Health Assembly share the same commitment.”














COTS 2024